Highlights Fagron N.V.

Equities

Market Closed - Euronext Bruxelles Other stock markets 11:35:47 2024-04-30 am EDT			After market 12:01:16 pm
18.24 ^EUR	+0.22%		18.23	-0.05%

Apr. 11	Transcript : Fagron NV, Q1 2024 Sales/ Trading Statement Call, Apr 11, 2024
Apr. 11	Fagron Reports Revenue Results for the First Quarter Ended 31 March 2024	CI

Fagron Provides Earnings Guidance for the Fiscal Year 2024	Apr. 11	CI
Fagron NV Proposes Dividend	Feb. 15	CI
Fagron NV Provides Earnings Guidance for the Full Year 2024	Feb. 15	CI
Fagron NV Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 14	CI
Fagron NV completed the acquisiton of Parma Produkt Gyógyszergyártó Korlátolt Felelosségu Társaság.	Jan. 22	CI
Fagron Seeks Acquisitions	23-10-12	CI
Fagron Nv Provides Earnings Guidance for 2023	23-10-12	CI
Fagron NV signed an agreement to acquire Parma Produkt Gyógyszergyártó Korlátolt Felelosségu Társaság.	23-10-11	CI
Fagron Completes Share Buyback Program	23-09-20	MT
Tranche Update on Fagron NV's Equity Buyback Plan announced on August 3, 2023.	23-09-19	CI
Fagron NV's Equity Buyback announced on August 3, 2023, has closed with 138,372 shares, representing 0.19% for ?2.26 million.	23-09-18	CI
Fagron NV Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-03	CI
Fagron NV Provides Earnings Guidance for the Full Year 2023	23-08-03	CI
Fagron Seeks M&A	23-08-03	CI
Fagron NV announces an Equity Buyback for 138,372 shares.	23-08-03	CI
Fagron NV intends to launch an Equity Buyback.	23-08-03	CI
Fagron NV authorizes a Buyback Plan.	23-08-02	CI
Ex-dividend day for final dividend	23-05-14	FA
Fagron NV Approves Dividend for the Fiscal Year 2022, Payable on 17 May 2023	23-05-08	CI
Fagron NV acquired Wildlife Pharmaceuticals.	23-03-30	CI

No results for this search